Poland· PL-100092909
Legalon 140
A silymarin product containing silybi mariani fructus extractum siccum, registered in Poland by Viatris Healthcare Sp. z o.o.. The same ATC class is registered in 5 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Silymarin is registered in 5 of 19 countries.
Countries holding a registration under ATC A05BA03 (silymarin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Silymarin · ATC A05BA03
5 / 19 countries
- Belgiumprice
- Czechiaprice
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Silybi mariani fructus extractum siccum
- Manufacturer
- Viatris Healthcare Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- A05BA03
- ATC class
- Silymarin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990473410
- gtin05909990473427
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Silymarin in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanySilymarin CtAbz-Pharma Gmbh
- FranceLEGALON 70 mg, comprimé enrobéCOOPER (ABRÉGÉ DE COOPERATION PHARMACEUTIQUE FRANCAISE)
- NorwayLegalon SILViatris
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Bulgaria · Карсил, Карсил Макс
- Czechia · Lagosa
- Germany · Silymarin Ct, Silymarin Forte Stada
- Spain · Legalon
- France · Legalon
- Croatia · Silymarin Belupo, Silymarin Forte Belupo
- Italy · Silimarin, Silmar
- Portugal · Legalon
- Romania · Silibină Arena
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/78d2e95b-896a-41c8-bc08-8f96fb1076a3 GET /v1/drugs/78d2e95b-896a-41c8-bc08-8f96fb1076a3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki twarde",
"source": "urpl",
"strength": "140 mg",
"packaging": "05909990473410 ¦ OTC ¦ 15233\n20 kaps.\n05909990473427 ¦ OTC ¦ 15234\n100 kaps.",
"substance": "Sylibi mariani fructus extractum siccum (wyciąg standaryzowany DER 36-44:1, ekstrahent: octan etylu 98% V/V) 140 mg + Silybi mariani extractum siccum 140 mg",
"common_name": "Silybi mariani fructus extractum siccum",
"pl_product_id": "100092909",
"pozwolenie_nr": "04734",
"auth_procedure": "NAR",
"authorisation_validity": "2025-05-09"
}See everything about silymarin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.